Oliver Cornely

Oliver Cornely is Director & Chair of Translational Research at the CECAD Institute of the University of Cologne, and Scientific Director of the Center for Clinical Trials. Clinically, he serves as Infectious Diseases Consultant at the University Hospital of Cologne, Germany. He is board certified in internal medicine, infectious diseases, haematology, oncology, and emergency medicine, and holds degrees in medical mycology and travel medicine. Originating from an HIV/AIDS clinical research group, Dr Cornelys research interest centres on infections in immunocompromised hosts, including invasive fungal diseases, antimicrobial resistance, Clostridium difficile infection, and vaccine preventable infections. Oliver Cornely is immediate-past President of the European Confederation of Medical Mycology (ECMM), the roof organization of 25 national mycology societies, and did set up ECMM Guideline Program, ECMM Academy (Fellows program), and ECMM Excellence Center Initiative, designating clinical and microbiological excellence centres after an international audit procedure. He is currently on the Board of Directors of the US Mycoses Study Group Education & Research Consortium (MSGERC), is founder and chair of the Infectious Diseases Scientific Working Group of the European Hematology Association (EHA). Oliver Cornely is a member of the Council of the International Society for Human and Animal Mycology (ISHAM) and was recently elected as Chair of the Infectious Diseases Working Party (AGIHO), a working group of the German Society for Haematology and Oncology (DGHO). Oliver Cornely coordinates guidelines on invasive fungal infections and currently collaborates with mycologists from more than 50 countries on tailoring management guidelines to health care settings throughout the world. He published over 500 peer-reviewed articles, books, book chapters, and electronic media; runs the YouTube® channel ID in Motion™, and ranks among the Top 1% most cited researchers. He is a reviewer for numerous medical scientific journals, editorial board member for Haematologica, and Infectious Disease, and Editor-in-Chief of Mycoses.